Michael Saxon is an accomplished consumer products executive with over 25 years of experience growing F100 businesses in the USA, Europe and Asia. He brings a strong innovative mindset from his experience creating new products and brands, and he has been the catalyst for successful large-scale transformation initiatives to drive organic growth and executing M&A transactions to enter new markets.

Mr. Saxon previously was the CEO of SXN Strategy Partners, which he founded in 2017 in Richmond, VA to advise primarily private equity firms on growth strategies and execution plans. That same year Michael helped build Trolley Ventures, Richmond’s only seed-round institutional venture capital firm.

His extensive international experience came from expat assignments in Central/ Eastern Europe, Taiwan, Malaysia and Scandinavia with Philip Morris International (PMI). Each market presented different go-to-market models and challenging regulatory environments. His international experience culminated in a CEO role in Scandinavia.

After his years abroad with PMI, Mr. Saxon returned to the U.S. in 2012 to work with Altria Group. He initially ran Altria Ventures Inc., then moved back into a general management role with P&L responsibility of Altria’s second largest business with $3.5B in revenue.

He graduated from the University of Georgia with a Bachelor in Business Administration with a major in Marketing. He is also on the board of Special Olympics Virginia.

(Philip) Blair Mullin is managing director of Somerset Associates LLC, a CFO, accounting, tax and financial consulting company, and serves on the board of CanaQuest Medical Corp. He has 30 years’ experience as CFO, COO, and in consulting and turnarounds for businesses with revenues of less than $100 million.

Since 2009, he has operated primarily in consulting and interim CFO roles in multiple sectors including fintech, blockchain, drones, recycling, medical marijuana, and electrical power generation. From 2003-09, Blair was a partner of Tatum Partners, a human capital firm engaged in providing CFO services. Within Tatum, Blair served in numerous leadership roles: from 2006-09, as CFO of Zi Corporation, a leading software development company specializing in mobile phones, which was sold in April 2009 to Nuance Communications; from 2003-06, as interim CFO of Homax Products, Vice President Finance of Yakima Products, and as a consultant in several engagements in industrial construction, manufacturing and air transportation; from 2001-03, as turnaround consultant to companies in the telecom sector during the critical post-9/11 timeframe; from 1995-2001, he was engaged in various C-level capacities in a public entity that was restructured and eventually became International DisplayWorks, a manufacturer of LCD displays based in Rocklin, California with operations in Shenzhen, China, which was later sold to Flextronics.

Mr. Mullin began his career in banking in 1982 after completing his MBA from University of Western Ontario Richard Ivey School of Business in London, Ontario, Canada and BA in Economics from Wilfrid Laurier University.  He currently resides in the Charlotte, North Carolina area.

Dr. Delon Human, M.B.Ch.B., M.Prax.Med, MFGP, DCH, MBA is a recognized global health leader, published author,  lecturer and healthcare consultant specializing in global health strategy, corporate and product transformation, harm reduction, access to healthcare and health communication. He is president of Health Diplomats, a specialized health, nutrition and wellness consulting group operating worldwide with clients including Fortune 500 companies, foundations, governments and NGOs such as the World Medical Association, World Dental Federation and the International Food and Beverage Alliance (IFBA).

He has acted as adviser to the WHO Director-General and to UN Secretary-General Ban Ki Moon. Until 2014, he served as Secretary-General and Special Envoy to WHO / UN of the International Food and Beverage Alliance, a group of leading food and non-alcoholic beverage companies with a global presence. For eight years, Dr. Human was secretary general of the World Medical Association (WMA) where he worked closely with the American Medical Association, WHO and FDA leadership involved in research ethics. He was instrumental in the establishment of the World Health Professions Alliance. In 2006 he was elected Secretary-General of the Africa Medical Association (AfMA). He is a fellow of the Russian and Romanian Academies of Medical Sciences.

Dr. Human was a clinician for two decades, part of the pediatric endocrinology research unit at the John Radcliffe Hospital and was involved in the establishment of several medical centers, a hospital and an emergency clinic in South Africa. Concurrently, he established a healthcare insurance company, Human Health Care, which provided strategic planning, medical audits and consumer care services to around 250,000 insured clients of several health funds. Dr. Human qualified as a physician in South Africa and completed his postgraduate studies in family medicine and child health in South Africa and Oxford, England. His business studies (MBA) were completed at the Edinburgh Business School.

Mario Gobbo has 35 years of banking and corporate finance experience in healthcare and energy. His expertise encompasses venture capital and private equity as well as investment banking and strategic advisory services. He serves on the Supervisory Board of Cinkarna Celje, a fine chemicals company from Slovenia. He is on the board of Zavarovalnica Triglav, the largest Slovene insurance company spearheading healthcare insurance in Central Europe and was Chairman of the Board and Chair of the Audit Committee of Helix BioPharma, a Toronto-listed biotech company developing interesting novel complex biomolecules to combat various cancers.  As an executive director, he was also on the board of Lazard Brothers, London.

While Managing Director for Health Care Capital Markets and Advisory with Natixis Bleichroeder in New York, from 2006 to 2009, he secured transactions for the bank’s M&A and equity capital markets pharmaceuticals and life sciences group. He obtained mandates for several IPOs and follow-on transactions on NASDAQ, as well as advisory assignments for health care and medical devices companies. When with the International Finance Corporation, a World Bank Group institution dealing with private sector investments, the team he led completed several highly successful equity and loan investments in biotech and generic pharmaceutical companies and funds in India, Latin America, China and Central Europe. From 1993 to 2001, he was with Lazard in London, where he created and managed their Central and Eastern European operations, including Turkey. Mr. Gobbo advised on M&A, fundraising and privatization efforts for several key firms in the region, including transactions for the pharmaceutical companies Pliva, Bosnalijek, Lek and Krka and investments in the APDC Biotech fund, now renamed VentureEast, one of the first Indian life sciences funds, and BVCF, a highly successful and innovative healthcare fund in China.  Prior to Lazard, he worked with Swiss Bank Corporation International Ltd. in London, where he worked on the IPO of Ares Serono, the Swiss biotech company, subsequently sold to Merck KgaA.  He was also on the investment committee of AHF, an India focused health care fund, Ocimum Biosolutions/Genelogic, an Indian contract research organization, and CellPraxis, a US/Brazilian stem cell research, privately owned firm.

Mario Gobbo holds a Bachelor of Arts in Organic Chemistry from Harvard College, a Master of Science in Biochemistry from the University of Colorado and an MBA, a Master of Business Economics and a PhD (Management) from the Wharton School of the University of Pennsylvania.

Mark Radke is a lawyer with a distinguished career in the area of financial services, specializing in federal securities regulation. As the Chief of Staff of the Securities and Exchange Commission under Chairman Harvey Pitt, he was responsible for that agency’s rulemaking in response to the Sarbanes Oxley Act. In private practice, as partner at several multinational law firms, he has represented corporations, brokerage and accounting firms, hedge funds and individuals on corporate governance, compliance, and regulatory issues involving not only the SEC but other federal and state regulators.

He was active in advising clients on legislative initiatives that lead to the Dodd-Frank Act of 2010, and in subsequent efforts to extend, implement or amend various components of that and other federal securities legislation.

Based in the Washington, D.C. area, Mr. Radke has advised political action committees and other entities in past election cycles. As an adjunct professor at the Georgetown University Law Center, he has taught classes in aspects of securities regulation since 1999. He holds a B.A. from the University of Washington, J.D. from the University of Baltimore and LL.M., Securities Regulation from Georgetown University Law Center.

Michael Saxon is an accomplished consumer products executive with over 25 years of experience growing F100 businesses in the USA, Europe and Asia. He brings a strong innovative mindset from his experience creating new products and brands, and he has been the catalyst for successful large-scale transformation initiatives to drive organic growth and executing M&A transactions to enter new markets.

Mr. Saxon previously was the CEO of SXN Strategy Partners, which he founded in 2017 in Richmond, VA to advise primarily private equity firms on growth strategies and execution plans. That same year Michael helped build Trolley Ventures, Richmond’s only seed-round institutional venture capital firm.

His extensive international experience came from expat assignments in Central/ Eastern Europe, Taiwan, Malaysia and Scandinavia with Philip Morris International (PMI). Each market presented different go-to-market models and challenging regulatory environments. His international experience culminated in a CEO role in Scandinavia.

After his years abroad with PMI, Mr. Saxon returned to the U.S. in 2012 to work with Altria Group. He initially ran Atria Ventures Inc., then moved back into a general management role with P&L responsibility of Altria’s second largest business with $3.5B in revenue.

He graduated from the University of Georgia with a Bachelor in Business Administration with a major in Marketing. He is also on the board of Special Olympics Virginia.